NCT02884557View on ClinicalTrials.gov

NKT Role in the Regulation of the Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 27, 2019

Study Completion Date

August 28, 2019

Conditions
Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
Interventions
OTHER

collection of gut biopsies collection of blood samples

Four to eight colon biopsies will be sampled during endoscopy. Thirty milliliters of blood will be sampled.

Trial Locations (1)

Unknown

CHRU, Hôpital Claude Huriez, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT02884557 - NKT Role in the Regulation of the Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter